Wealth Management Partners LLC boosted its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 78.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,319 shares of the company’s stock after acquiring an additional 11,979 shares during the period. Wealth Management Partners LLC owned about 0.06% of ARK Genomic Revolution ETF worth $1,481,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Ascentis Independent Advisors acquired a new stake in shares of ARK Genomic Revolution ETF in the first quarter valued at approximately $26,000. GK Wealth Management LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter worth approximately $27,000. PNC Financial Services Group Inc. raised its position in shares of ARK Genomic Revolution ETF by 53.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after purchasing an additional 378 shares during the last quarter. Western Wealth Management LLC purchased a new stake in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $37,000. Finally, Hilton Head Capital Partners LLC lifted its stake in ARK Genomic Revolution ETF by 161.4% in the 1st quarter. Hilton Head Capital Partners LLC now owns 1,537 shares of the company’s stock valued at $41,000 after buying an additional 949 shares in the last quarter.
ARK Genomic Revolution ETF Stock Up 2.5%
ARKG stock opened at $49.85 on Thursday. The stock’s 50 day moving average price is $49.12 and its 200 day moving average price is $39.97. ARK Genomic Revolution ETF has a 1 year low of $24.60 and a 1 year high of $58.83.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
See Also
- Five stocks we like better than ARK Genomic Revolution ETF
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
